Katsumi Ueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katsumi Ueno has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Norihiko Morita
Department of Cardiology, Matsunami General Hospital , Kasamatsu, Gifu 501-6062
6 shared publicationsYoshinobu Kojima
Department of Cardiology, Matsunami General Hospital , Kasamatsu, Gifu 501-6062
5 shared publicationsHiroki Kondo
Department of Cardiology Matsunami General Hospital Kasamatsu Japan
3 shared publicationsMasayasu Esaki
Department of Cardiology Matsunami General Hospital Kasamatsu Japan
3 shared publicationsShingo Minatoguchi
Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
3 shared publicationsYu Ando
Department of Cardiology Matsunami General Hospital Kasamatsu Japan
3 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (5)
Isolated cardiac sarcoidosis presenting as tumour-like multiple cardiac masses with massive pericardial effusion
- 30 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (5)
Open AccessIsolated cardiac sarcoidosis presenting as tumour-like multiple cardiac masses with massive pericardial effusion
- Open Access
- 10 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae492
Long-term efficacy of drug-coated balloon only angioplasty for IgG4-related coronary artery disease: a case report
Background: Although coronary artery involvement in patients with IgG4-related disease (IgG4-RD) is rare, emergency revascularization is recommended for managing acute coronary syndrome. However, coronary aneurysm formation and stent migration after sirolimus-eluting stent implantation have been reported for this disease. Thus, new treatment modalities are warranted for the management of coronary artery disease in this vasculitis. Case summary: A 70-year-old male who experienced progressive chest discomfort for 1 month underwent cardiac examination. Coronary computed tomography angiography (CCTA) revealed right coronary artery hypoplasia, coronary artery aneurysm with severely calcified stenosis in the proximal left anterior descending artery (LAD), and subtotal obstruction in the mid-LAD. The left circumflex artery (LCX) also had stenosis and dilated lesions. Additionally, diffuse perivascular soft tissue thickening was observed in the mid-LCX. The percutaneous coronary intervention was performed for the proximal- and mid-LAD lesions. Rotational atherectomy with low-pressure drug-coated balloon (DCB) dilation was considered for these lesions owing to suspicion of vasculitis. The patient was later diagnosed with Sjögren’s syndrome and IgG4-RD overlap syndrome. Oral steroids and immunosuppressive drugs were initiated. In a follow-up at 7 and 26 months, late lumen enlargement was observed in the treated area of the LAD, without enlargement of the adjacent aneurysm. CCTA performed after 26 months revealed resolution of the diffuse perivascular soft tissue thickening in the mid-LCX. Discussion: To our knowledge, this is the first case report demonstrating favourable outcomes for treatment of a coronary artery lesion attributed to IgG4-RD with DCB, leaving nothing implanted in the coronary artery tree.
- 10 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae492
Open AccessLong-term efficacy of drug-coated balloon only angioplasty for IgG4-related coronary artery disease: a case report
Background: Although coronary artery involvement in patients with IgG4-related disease (IgG4-RD) is rare, emergency revascularization is recommended for managing acute coronary syndrome. However, coronary aneurysm formation and stent migration after sirolimus-eluting stent implantation have been reported for this disease. Thus, new treatment modalities are warranted for the management of coronary artery disease in this vasculitis. Case summary: A 70-year-old male who experienced progressive chest discomfort for 1 month underwent cardiac examination. Coronary computed tomography angiography (CCTA) revealed right coronary artery hypoplasia, coronary artery aneurysm with severely calcified stenosis in the proximal left anterior descending artery (LAD), and subtotal obstruction in the mid-LAD. The left circumflex artery (LCX) also had stenosis and dilated lesions. Additionally, diffuse perivascular soft tissue thickening was observed in the mid-LCX. The percutaneous coronary intervention was performed for the proximal- and mid-LAD lesions. Rotational atherectomy with low-pressure drug-coated balloon (DCB) dilation was considered for these lesions owing to suspicion of vasculitis. The patient was later diagnosed with Sjögren’s syndrome and IgG4-RD overlap syndrome. Oral steroids and immunosuppressive drugs were initiated. In a follow-up at 7 and 26 months, late lumen enlargement was observed in the treated area of the LAD, without enlargement of the adjacent aneurysm. CCTA performed after 26 months revealed resolution of the diffuse perivascular soft tissue thickening in the mid-LCX. Discussion: To our knowledge, this is the first case report demonstrating favourable outcomes for treatment of a coronary artery lesion attributed to IgG4-RD with DCB, leaving nothing implanted in the coronary artery tree.
- Open Access
- 25 February 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 101 (4) , 713-721
Serial quantitative angiographic study of target lumen enlargement after drug‐coated balloon angioplasty for native coronary artery disease
Background: Target lumen enlargement (TLE) or “late lumen enlargement” is often encountered after percutaneous coronary intervention (PCI) with drug‐coated balloons (DCB). To date, the prognosis of coronary arterial lesions with or without TLE has not been clearly elucidated.Aims: This study aimed to assess the long‐term prognosis of coronary arterial lesions with or without TLE observed within 1 year (early TLE) after DCB angioplasty using serial quantitative angiographic follow‐up.Methods: One hundred and ninety‐three consecutive patients (de novo coronary arterial lesions, 251) who underwent follow‐up angiography within 1 year after DCB angioplasty (early follow‐up, median: 6 months) were retrospectively evaluated. Of these, 97 patients (125 lesions) also underwent angiography more than 1 year after DCB angioplasty (late follow‐up, median: 37 months). TLE was defined as an increase in minimal lumen diameter (MLD) after PCI at each follow‐up.Results: Early TLE was detected in 142 lesions (56.6%). Of these, 76 lesions were also evaluated at late follow‐up. TLE persisted even at late follow‐up in 67 of the 76 lesions (88.2%). An increase in MLD in early TLE (+) lesions was observed in the period between post‐PCI and early follow‐up (1.84 ± 0.06 vs. 2.12 ± 0.07 mm, p < 0.001) but not between early and late follow‐up (2.12 ± 0.07 vs. 2.16 ± 0.07 mm, p = 0.74). In contrast, 49 of 109 lesions without early TLE were evaluated at late follow‐up, of which 28 lesions (57.1%) showed TLE at late follow‐up. The MLD of early TLE (−) lesions (n = 49) significantly increased from early (1.63 ± 0.061 mm) to late follow‐up (1.84 ± 0.06 mm) (p < 0.001). No aneurysms were found in any of these cases.Conclusion: Early TLE was observed in more than half of the lesions, with the majority remaining at late follow‐up. Alternatively, half of the lesions without early TLE showed late TLE, occurring biphasically after DCB angioplasty.
- 25 February 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 101 (4) , 713-721
Open AccessSerial quantitative angiographic study of target lumen enlargement after drug‐coated balloon angioplasty for native coronary artery disease
Background: Target lumen enlargement (TLE) or “late lumen enlargement” is often encountered after percutaneous coronary intervention (PCI) with drug‐coated balloons (DCB). To date, the prognosis of coronary arterial lesions with or without TLE has not been clearly elucidated.Aims: This study aimed to assess the long‐term prognosis of coronary arterial lesions with or without TLE observed within 1 year (early TLE) after DCB angioplasty using serial quantitative angiographic follow‐up.Methods: One hundred and ninety‐three consecutive patients (de novo coronary arterial lesions, 251) who underwent follow‐up angiography within 1 year after DCB angioplasty (early follow‐up, median: 6 months) were retrospectively evaluated. Of these, 97 patients (125 lesions) also underwent angiography more than 1 year after DCB angioplasty (late follow‐up, median: 37 months). TLE was defined as an increase in minimal lumen diameter (MLD) after PCI at each follow‐up.Results: Early TLE was detected in 142 lesions (56.6%). Of these, 76 lesions were also evaluated at late follow‐up. TLE persisted even at late follow‐up in 67 of the 76 lesions (88.2%). An increase in MLD in early TLE (+) lesions was observed in the period between post‐PCI and early follow‐up (1.84 ± 0.06 vs. 2.12 ± 0.07 mm, p < 0.001) but not between early and late follow‐up (2.12 ± 0.07 vs. 2.16 ± 0.07 mm, p = 0.74). In contrast, 49 of 109 lesions without early TLE were evaluated at late follow‐up, of which 28 lesions (57.1%) showed TLE at late follow‐up. The MLD of early TLE (−) lesions (n = 49) significantly increased from early (1.63 ± 0.061 mm) to late follow‐up (1.84 ± 0.06 mm) (p < 0.001). No aneurysms were found in any of these cases.Conclusion: Early TLE was observed in more than half of the lesions, with the majority remaining at late follow‐up. Alternatively, half of the lesions without early TLE showed late TLE, occurring biphasically after DCB angioplasty.
- Open Access
- 27 December 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-10
Efficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease
Objectives. This study sought to assess the efficacy of oversized drug-coated balloon (DCB) inflation at low pressure for the prevention of acute dissections and late restenosis. Background. The major limitation of DCB coronary angioplasty is the occurrence of severe dissection after inflation of DCB. Methods. Between 2014 and 2018, 273 consecutive patients were retrospectively studied. 191 lesions (154 patients) treated by oversized DCB inflation at low pressure (Results. Although the lesions in the LP group were more complex than those in the SP group (smaller reference diameter (2.38 mm vs. 2.57 mm, ), longer lesions (11.7 mm vs. 10.5 mm, ), and more frequent use of rotational atherectomy (45.0% vs. 28.1%, ), there was no significant difference in the NHLBI type of dissections between the two groups (11.5%, 12.0%, 5.2% vs. 12.6%, 12.6%, 2.2% in type A, B, and C, ), and no bailout stenting was required. In 125 well-matched lesion pairs after propensity score analysis, the cumulative incidence of target lesion revascularization at 3 years was 4.5% vs. 7.0%, respectively ( ). Late lumen loss (−0.00 mm vs. −0.01 mm, ) and restenosis rates (7.4% vs. 7.1%, ) were similar in both of the groups. Conclusion. The application of oversized DCB at low pressure is effective and feasible for preventing late restenosis comparative to the standard technique of DCB.
- 27 December 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-10
Open AccessEfficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease
Objectives. This study sought to assess the efficacy of oversized drug-coated balloon (DCB) inflation at low pressure for the prevention of acute dissections and late restenosis. Background. The major limitation of DCB coronary angioplasty is the occurrence of severe dissection after inflation of DCB. Methods. Between 2014 and 2018, 273 consecutive patients were retrospectively studied. 191 lesions (154 patients) treated by oversized DCB inflation at low pressure (Results. Although the lesions in the LP group were more complex than those in the SP group (smaller reference diameter (2.38 mm vs. 2.57 mm, ), longer lesions (11.7 mm vs. 10.5 mm, ), and more frequent use of rotational atherectomy (45.0% vs. 28.1%, ), there was no significant difference in the NHLBI type of dissections between the two groups (11.5%, 12.0%, 5.2% vs. 12.6%, 12.6%, 2.2% in type A, B, and C, ), and no bailout stenting was required. In 125 well-matched lesion pairs after propensity score analysis, the cumulative incidence of target lesion revascularization at 3 years was 4.5% vs. 7.0%, respectively ( ). Late lumen loss (−0.00 mm vs. −0.01 mm, ) and restenosis rates (7.4% vs. 7.1%, ) were similar in both of the groups. Conclusion. The application of oversized DCB at low pressure is effective and feasible for preventing late restenosis comparative to the standard technique of DCB.
- Open Access
- 7 January 2020
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (7) , 665-667
Acute diffuse thickening like ‘halo’ of the coronary tunica adventitia after rotational atherectomy
An abstract is unavailable. This article is available as a PDF only.
- 7 January 2020
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (7) , 665-667
Open AccessAcute diffuse thickening like ‘halo’ of the coronary tunica adventitia after rotational atherectomy
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 13 March 2019
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2019, 1-10
Safety and Long-Term Efficacy of Drug-Coated Balloon Angioplasty following Rotational Atherectomy for Severely Calcified Coronary Lesions Compared with New Generation Drug-Eluting Stents
Objectives. This study sought to assess the safety and long-term efficacy of drug-coated balloons (DCB) following aggressive intracoronary image-guided rotational atherectomy (iRA) for severe coronary artery calcification (CAC), and to compare this strategy with new generation drug-eluting stents (nDES) following iRA. Background. Ischemic events following the treatment of CAC is still relatively high. Thus, more innovative strategies are required. Methods. We evaluated 123 consecutive patients (166 lesions) with de novo CAC undergoing an iRA (burr size; 0.7 of the mean reference diameter by intracoronary imaging) followed by DCB (DCB-iRA; 54 patients, 68 lesions) or nDES (nDES-iRA; 69 patients, 98 lesions). Follow-up angiography was obtained at > 6 months. Results. The target vessels (right coronary and circumflex), bifurcation (67.6% versus 47.9%), reference diameter (2.28mm versus 2.49mm), and lesion length (11.89mm versus 18.78mm) were significantly different between the two groups. The median follow-up was 732 days. TLR and TVR in DCB-iRA and nDES-iRA at 3 years were similar: 15.6% versus 16.3% (P=0.99) and 15.6% versus 23.3% (P=0.38). In 41 well-matched lesion pairs after propensity score analysis, the cumulative incidence of TLR and TVR in DCB-iRA and nDES-iRA at 3 years was 12.9% versus 16.3% (P=0.70) and 12.9% versus 26.1% (P=0.17), respectively. On QCA analysis, although the acute gain was smaller in DCB-iRA (0.85 mm versus 1.53 mm, P Conclusions. DCB-iRA is feasible for CAC.
- 13 March 2019
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2019, 1-10
Open AccessSafety and Long-Term Efficacy of Drug-Coated Balloon Angioplasty following Rotational Atherectomy for Severely Calcified Coronary Lesions Compared with New Generation Drug-Eluting Stents
Objectives. This study sought to assess the safety and long-term efficacy of drug-coated balloons (DCB) following aggressive intracoronary image-guided rotational atherectomy (iRA) for severe coronary artery calcification (CAC), and to compare this strategy with new generation drug-eluting stents (nDES) following iRA. Background. Ischemic events following the treatment of CAC is still relatively high. Thus, more innovative strategies are required. Methods. We evaluated 123 consecutive patients (166 lesions) with de novo CAC undergoing an iRA (burr size; 0.7 of the mean reference diameter by intracoronary imaging) followed by DCB (DCB-iRA; 54 patients, 68 lesions) or nDES (nDES-iRA; 69 patients, 98 lesions). Follow-up angiography was obtained at > 6 months. Results. The target vessels (right coronary and circumflex), bifurcation (67.6% versus 47.9%), reference diameter (2.28mm versus 2.49mm), and lesion length (11.89mm versus 18.78mm) were significantly different between the two groups. The median follow-up was 732 days. TLR and TVR in DCB-iRA and nDES-iRA at 3 years were similar: 15.6% versus 16.3% (P=0.99) and 15.6% versus 23.3% (P=0.38). In 41 well-matched lesion pairs after propensity score analysis, the cumulative incidence of TLR and TVR in DCB-iRA and nDES-iRA at 3 years was 12.9% versus 16.3% (P=0.70) and 12.9% versus 26.1% (P=0.17), respectively. On QCA analysis, although the acute gain was smaller in DCB-iRA (0.85 mm versus 1.53 mm, P Conclusions. DCB-iRA is feasible for CAC.
- Open Access
- 1 September 2007
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 57 (09) , 573-581
Effects of Benidipine and Some Other Calcium Channel Blockers on the Prognosis of Patients with Vasospastic Angina
Background: It has been reported that the morbidity rate of vasospastic angina is higher in Japan compared to western countries, and its prognosis has already been reported. However, the prognosis of vasospastic angina in relation to coronary angiographic findings, prognostic risk factors and treatment has not yet been fully investigated. Methods and results: From January 2000 to October 2005, 1047 patients with va-sospastic angina diagnosed by coronary angiography at Gifu University Hospital and related hospitals were registered in a cohort study (follow-up rate: 91.4 %, median follow-up duration: 3.8 years). The presence of coronary artery stenosis, diabetes mellitus, total spasm, and age of more than 65 years had a negative prognostic impact on cardiovascular events. Patients were treated with calcium channel blockers such as diltiazem (CAS 33286-22-5, CAS 42399-41-7), am-lodipine (CAS 111470-99-6), nifedipine (CAS 21829-25-4), and benidipine (CAS 91599-74-5). Among these calcium channel blockers, when patient background was matched by the propensity score in patients treated with calcium channel blockers only, the cardiovascular event rate was significantly lower in the benid-ipine group than in the diltiazem group. Conclusion: The study demonstrated for the first time that total spasm is a risk factor, independent of other factors, for cardiovascular events in patients with va-sospastic angina. Treatment with benid-ipine showed a better prognosis than that with diltiazem.
- 1 September 2007
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 57 (09) , 573-581
Open AccessEffects of Benidipine and Some Other Calcium Channel Blockers on the Prognosis of Patients with Vasospastic Angina
Background: It has been reported that the morbidity rate of vasospastic angina is higher in Japan compared to western countries, and its prognosis has already been reported. However, the prognosis of vasospastic angina in relation to coronary angiographic findings, prognostic risk factors and treatment has not yet been fully investigated. Methods and results: From January 2000 to October 2005, 1047 patients with va-sospastic angina diagnosed by coronary angiography at Gifu University Hospital and related hospitals were registered in a cohort study (follow-up rate: 91.4 %, median follow-up duration: 3.8 years). The presence of coronary artery stenosis, diabetes mellitus, total spasm, and age of more than 65 years had a negative prognostic impact on cardiovascular events. Patients were treated with calcium channel blockers such as diltiazem (CAS 33286-22-5, CAS 42399-41-7), am-lodipine (CAS 111470-99-6), nifedipine (CAS 21829-25-4), and benidipine (CAS 91599-74-5). Among these calcium channel blockers, when patient background was matched by the propensity score in patients treated with calcium channel blockers only, the cardiovascular event rate was significantly lower in the benid-ipine group than in the diltiazem group. Conclusion: The study demonstrated for the first time that total spasm is a risk factor, independent of other factors, for cardiovascular events in patients with va-sospastic angina. Treatment with benid-ipine showed a better prognosis than that with diltiazem.